Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.930
-0.080 (-2.66%)
At close: Apr 1, 2025, 4:00 PM
2.960
+0.030 (1.01%)
After-hours: Apr 1, 2025, 4:10 PM EDT

Kiora Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
910461927
Upgrade
Market Cap Growth
146.53%146.53%-34.81%-67.75%-29.68%-33.02%
Upgrade
Enterprise Value
-18-19-11825
Upgrade
Last Close Price
3.013.304.7030.87543.601774.80
Upgrade
PE Ratio
3.352.76----
Upgrade
PS Ratio
0.730.62---2252.98
Upgrade
PB Ratio
0.350.380.660.541.312.79
Upgrade
P/TBV Ratio
0.380.380.670.551.334.60
Upgrade
P/FCF Ratio
1.061.16----
Upgrade
P/OCF Ratio
1.061.16----
Upgrade
EV/Sales Ratio
----2038.07
Upgrade
Debt / Equity Ratio
0.000.000.020.010.010.06
Upgrade
Debt / EBITDA Ratio
0.010.01----
Upgrade
Debt / FCF Ratio
0.010.01----
Upgrade
Asset Turnover
0.640.64---0.00
Upgrade
Quick Ratio
4.604.602.762.245.210.64
Upgrade
Current Ratio
4.944.942.902.355.590.87
Upgrade
Return on Equity (ROE)
22.56%22.56%-142.88%-104.54%-113.30%-83.93%
Upgrade
Return on Assets (ROA)
13.64%13.64%-33.54%-34.55%-37.30%-36.91%
Upgrade
Return on Capital (ROIC)
21.37%21.37%-61.27%-50.98%-52.67%-55.15%
Upgrade
Return on Capital Employed (ROCE)
18.00%18.00%----
Upgrade
Earnings Yield
39.80%36.30%-311.53%-220.45%-72.08%-25.26%
Upgrade
FCF Yield
94.69%86.37%-237.92%-169.24%-56.21%-27.01%
Upgrade
Buyback Yield / Dilution
-666.73%-666.73%-561.21%-203.73%-110.04%-
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q